N-[N-[3-(3-methoxy-4-hydroxyphenyl)propyl]-L--aspartyl]-L-phenylalanine
1-methyl ester is prepared by a process comprising:
- subjecting Aspartame and 3-(3-methoxy-4-hydroxyphenyl)propionaldehyde
or derivatives thereof to reductive alkylation in a solvent to produce N-[N-[3-(3-methoxy-4-hydroxyphenyl)propyl]-L--aspartyl]-L-phenylalanine
1-methyl ester; and
- crystallizing said compound.